Profile data is unavailable for this security.
About the company
Veritas In Silico Inc is a Japan-based company primarily engaged in the pharmaceutical discovery platform business. The main business is small molecule drug discovery targeting messenger ribonucleic acid (mRNA) using the ibVIS platform, which integrates digital technology including in silico ribonucleic acid (RNA) structural analysis technology and drug discovery technology, through joint drug discovery research with pharmaceutical companies to create mRNA-targeted small molecule drugs.
- Revenue in JPY (TTM)--
- Net income in JPY--
- Incorporated2016
- Employees15.00
- LocationVeritas In Silico Inc1-11-1, NishigotandaSHINAGAWA-KU 141-0031JapanJPN
- Phone+81 364217537
- Websitehttps://www.veritasinsilico.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ribomic Inc | 2.11m | -949.28m | 3.30bn | 24.00 | -- | 1.00 | -- | 1,564.81 | -25.70 | -25.70 | 0.0577 | 80.86 | 0.0006 | -- | 0.0677 | 87,791.66 | -25.76 | -30.52 | -26.68 | -31.71 | -- | -- | -45,053.58 | -1,777.84 | 30.87 | -- | -- | -- | -100.00 | -- | 38.04 | -- | 4.42 | -- |
| Human Metabolome Technologies Inc | 1.35bn | 243.25m | 3.55bn | 58.00 | 14.59 | 1.82 | 10.78 | 2.64 | 41.12 | 41.12 | 227.58 | 329.08 | 0.5499 | 15.07 | 7.52 | 23,201,220.00 | 9.94 | 8.49 | 12.91 | 10.80 | 64.60 | 69.25 | 18.08 | 13.21 | 3.25 | -- | 0.1041 | 18.31 | 3.57 | -- | -14.88 | -- | -- | -- |
| BrightPath Biotherapeutics Co Ltd | 84.00k | -1.15bn | 4.18bn | 24.00 | -- | 3.33 | -- | 49,753.26 | -16.73 | -16.73 | 0.0012 | 14.73 | 0.00006 | -- | 2.80 | 3,500.00 | -80.63 | -51.56 | -97.29 | -54.32 | 75.00 | 68.63 | -1,372,495.00 | -22,321.82 | -- | -- | 0.2085 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
| FunPep Co Ltd | 530.00k | -727.29m | 4.34bn | 15.00 | -- | 1.62 | -- | 8,193.92 | -29.40 | -29.40 | 0.0215 | 82.55 | 0.0002 | -- | -- | 35,333.33 | -26.27 | -27.10 | -29.12 | -28.75 | -- | -- | -137,223.40 | -815.82 | 5.06 | -1,004.01 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| Cyfuse Biomedical KK | 60.88m | -671.82m | 4.44bn | 21.00 | -- | 1.51 | -- | 72.94 | -84.88 | -84.88 | 7.71 | 360.49 | 0.0148 | 0.5613 | 24.17 | 2,899,143.00 | -16.32 | -- | -19.11 | -- | 58.30 | -- | -1,103.48 | -- | 6.02 | -84.25 | 0.2153 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| Kidswell Bio Corp | 3.60bn | -883.62m | 4.76bn | 42.00 | -- | 5.55 | -- | 1.32 | -22.75 | -22.75 | 92.50 | 21.08 | 0.9182 | 2.73 | 6.63 | 85,697,070.00 | -22.54 | -57.41 | -35.96 | -81.13 | 36.17 | 55.20 | -24.55 | -123.52 | 1.64 | -17.95 | 0.7132 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| DNA Chip Research Inc | 766.32m | -118.13m | 4.86bn | 37.00 | -- | 6.93 | -- | 6.34 | -18.29 | -18.29 | 116.80 | 103.64 | 0.9159 | 8.50 | 7.86 | 20,711,350.00 | -14.12 | -23.49 | -17.74 | -26.70 | 38.52 | 14.28 | -15.41 | -54.10 | 2.78 | -641.51 | -- | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
| Kringle Pharma Inc | 79.22m | -793.94m | 5.76bn | 13.00 | -- | 2.46 | -- | 72.65 | -134.08 | -134.08 | 13.09 | 344.17 | 0.0274 | -- | 1.66 | 6,093,462.00 | -27.49 | -19.00 | -29.10 | -20.23 | -- | -- | -1,002.26 | -156.51 | 30.96 | -- | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Carna Biosciences, Inc. | 1.40bn | -1.51bn | 6.08bn | 67.00 | -- | 2.16 | -- | 4.33 | -85.98 | -85.98 | 80.34 | 147.09 | 0.391 | 1.19 | 13.59 | 20,922,580.00 | -42.15 | -14.45 | -45.45 | -16.95 | 87.53 | 90.59 | -107.80 | -35.42 | 11.11 | -- | 0.0215 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Veritas In Silico Inc | -100.00bn | -100.00bn | 6.15bn | 15.00 | -- | 2.61 | -- | -- | -- | -- | -- | 363.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.22 | -- | 0.00 | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Chiome Bioscience Inc | 581.07m | -1.22bn | 6.68bn | 51.00 | -- | 5.39 | -- | 11.50 | -22.07 | -22.07 | 10.53 | 19.85 | 0.3371 | 5.16 | 8.01 | 11,393,550.00 | -70.61 | -50.50 | -95.97 | -57.38 | 53.55 | 57.53 | -209.45 | -224.74 | 3.57 | -894.37 | 0.1995 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| Noile-Immune Biotech Inc | 308.06m | -979.88m | 7.19bn | 28.00 | -- | 1.44 | -- | 23.33 | -22.63 | -22.63 | 7.11 | 115.62 | 0.0549 | 0.0625 | 6.35 | 11,002,180.00 | -17.47 | -- | -17.90 | -- | 99.80 | -- | -318.08 | -- | 66.40 | -- | 0.00 | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| OncoTherapy Science, Inc. | 478.75m | -1.12bn | 8.15bn | 54.00 | -- | 8.15 | -- | 17.02 | -4.86 | -4.86 | 2.04 | 3.68 | 0.3526 | 4.34 | 9.77 | 8,865,722.00 | -82.71 | -55.67 | -106.53 | -63.82 | -32.12 | -1.49 | -234.61 | -247.47 | 3.11 | -- | 0.0731 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
| Modalis Therapeutics Corp | 0.00 | -1.87bn | 8.54bn | 37.00 | -- | 2.77 | -- | -- | -52.79 | -52.79 | 0.00 | 44.35 | 0.00 | -- | -- | 0.00 | -74.95 | -29.19 | -78.46 | -30.02 | -- | -- | -- | -597.35 | 43.87 | -87.46 | 0.0771 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
| TMS Co Ltd | 0.00 | -1.10bn | 8.75bn | 14.00 | -- | 2.93 | -- | -- | -28.37 | -28.37 | 0.00 | 74.10 | 0.00 | -- | -- | 0.00 | -33.57 | -- | -34.42 | -- | -- | -- | -- | -- | 31.13 | -- | 0.00 | -- | -- | -- | -11.51 | -- | -- | -- |
| Linical Co Ltd | 12.15bn | 252.44m | 9.05bn | 662.00 | 32.75 | 1.01 | 11.50 | 0.7451 | 11.18 | 11.18 | 538.03 | 362.32 | 0.6633 | -- | 3.45 | 18,356,870.00 | 1.38 | 4.01 | 2.37 | 6.33 | 29.26 | 30.99 | 2.08 | 5.48 | -- | -- | 0.2518 | 50.81 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
Data as of Nov 13 2024. Currency figures normalised to Veritas In Silico Inc's reporting currency: Japanese Yen JPY
0.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 03 Oct 2024 | 7.80k | 0.12% |
Data from 31 Oct 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
